![FDA, FTC and DOJ Enforcement of Medical Device Regulations FDA, FTC and DOJ Enforcement of Medical Device Regulations](https://www.fdanews.com/ext/resources/Book-Covers-2/BFFDEMDR-COVER.png?height=200&t=1685733565&width=200)
Home » Abbott Gets FDA’s Premarket Approval for Aveir VR Leadless Pacemaker
Abbott Gets FDA’s Premarket Approval for Aveir VR Leadless Pacemaker
Abbott has received the FDA’s premarket approval for its Aveir single-chamber leadless pacemaker for patients with slow heart rhythms.
The device is implanted directly inside the heart's right ventricle via a minimally invasive procedure. It has a mapping capability that allows physicians to measure electrical signals within the heart to determine the correct placement of the device before final implantation.
The pacemaker features an extended battery life that can be up to two times longer than other commercially available leadless pacemakers, the company said.
Upcoming Events
-
21Oct